GelSana Therapeutics
PrivateLast Round
Seed Round
Mar 6, 2026
Total Funding Raised
$7.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
GelSana Therapeutics is a biomaterials company developing novel hydrogel wound dressings designed to reduce inflammation and provide sustained drug delivery for chronic wounds.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GelSana Therapeutics Comparables
Compare GelSana Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioMimir Inc. | 80% | |
| Omeza | 79% | |
| Tempo Therapeutics, Inc. | 78% |
GelSana Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 6, 2026 | ||||
| Grant | Jul 14, 2025 | ||||
| Accelerator | Jun 5, 2025 | ||||
| Grant | Sep 5, 2024 | ||||
| Seed | Feb 19, 2024 | ||||
Grant | Nov 16, 2023 |
GelSana Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| Advanced Industries Accelerator Program | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Innosphere Ventures | Pre Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased to 2, 2.5x the trailing average.
- Jul 13, 2026
Open roles increased from 0 to 2, representing 25% of headcount.
Recent news
Latest coverage and updates
- receives_awardJun 18, 2026
Babita Parajuli at GelSana Therapeutics inc receives award 2026 Robert B. Lindberg Basic Scientist Paper Award.
- receives_awardJun 18, 2026
GelSana Therapeutics inc receives award American Burn Association.
GelSana Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GelSana Therapeutics's valuation, stock price, and market status.
Is GelSana Therapeutics a public or private company?
GelSana Therapeutics is a private company.
What is the current stock price of GelSana Therapeutics?
GelSana Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is GelSana Therapeutics worth (valuation)?
Valuation information for GelSana Therapeutics is not publicly available.
Can I buy GelSana Therapeutics stock?
GelSana Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GelSana Therapeutics's last funding round?
GelSana Therapeutics's most recent funding round was Seed Round on March 6, 2026.
Who are the main investors in GelSana Therapeutics?
Key investors in GelSana Therapeutics include Innosphere Ventures, Innosphere Ventures.
Will GelSana Therapeutics IPO soon?
No public IPO plans have been announced for GelSana Therapeutics.
How can I track GelSana Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GelSana Therapeutics's secondary market activity and sign up for updates.